Da-Yong Zhou Selected Research

Autolysis

1/2022	Inhibition of ultraviolet-induced sea cucumber (Stichopus japonicus) autolysis by maintaining coelomocyte intracellular calcium homeostasis.
1/2020	Inhibitory effect of natural metal ion chelators on the autolysis of sea cucumber (Stichopus japonicus) and its mechanism.
12/2019	Effects of collagenase type I on the structural features of collagen fibres from sea cucumber (Stichopus japonicus) body wall.
10/2019	The role of matrix metalloprotease (MMP) to the autolysis of sea cucumber (Stichopus japonicus).
8/2018	Action of trypsin on structural changes of collagen fibres from sea cucumber (Stichopus japonicus).
2/2018	Structural and biochemical changes in dermis of sea cucumber (Stichopus japonicus) during autolysis in response to cutting the body wall.
10/2017	Effects of endogenous cysteine proteinases on structures of collagen fibres from dermis of sea cucumber (Stichopus japonicus).
12/2016	Changes in collagenous tissue microstructures and distributions of cathepsin L in body wall of autolytic sea cucumber (Stichopus japonicus).
11/2015	Analysis of Apoptosis in Ultraviolet-Induced Sea Cucumber (Stichopus japonicus) Melting Using Terminal Deoxynucleotidyl-Transferase-Mediated dUTP Nick End-Labeling Assay and Cleaved Caspase-3 Immunohistochemistry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Da-Yong Zhou Research Topics

Disease

9	Autolysis 01/2022 - 11/2015
3	Body Weight (Weight, Body) 01/2021 - 08/2013
3	Neoplasms (Cancer) 06/2019 - 08/2009
2	Hepatocellular Carcinoma (Hepatoma) 10/2017 - 01/2009
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018

Drug/Important Bio-Agent (IBA)

6	CollagenIBA 06/2022 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2018
2	CalciumIBA 01/2022 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 10/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 10/2019
2	EnzymesIBA 10/2019 - 10/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	ChitosanIBA 01/2021
1	Chelating AgentsIBA 01/2020
1	IonsIBA 01/2020
1	MetalsIBA 01/2020
1	Collagenases (Collagenase)FDA Link 12/2019
1	Proteoglycans (Proteoglycan)IBA 12/2019
1	Matrix Metalloproteinase InhibitorsIBA 10/2019
1	Hormones (Hormone)IBA 06/2019
1	Endocrine DisruptorsIBA 06/2019
1	TrypsinIBA 08/2018
1	Serine Proteases (Serine Protease)IBA 08/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	CaspasesIBA 01/2018
1	Cytochromes c (Cytochrome c)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 10/2017
1	salicylhydroxamic acid (SHAM)IBA 10/2017
1	Zoledronic Acid (Zometa)FDA Link 10/2017
1	Soybean Oil FDA LinkGeneric 03/2017
1	Cathepsin LIBA 12/2016
1	Caspase 3 (Caspase-3)IBA 11/2015
1	oxidized low density lipoproteinIBA 08/2013
1	FlavonesIBA 08/2009

Therapy/Procedure

1	Lasers (Laser) 01/2020
1	Oral Administration 03/2017
1	Transplantation 01/2009